A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens

Diagnostic Molecular Pathology

Volumn 7, Issue 6, 1998, Pages 317-323

  Feoli Fonseca, Juan Carlos ^a   Oligny, Luc L ^a   Filion, Mario ^a   Brochu, Pierre ^a   Simard, Pierre ^a   Russo, Pierre A ^a   Yotov, Wagner V ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cervical biopsy; Cervical intraepithelial neoplasia; Direct sequencing; GP5; Human papillomavirus; MY09; Polymerase chain reaction

Indexed keywords

ARTICLE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

EID: 0032426881     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199812000-00005     Document Type: Article

References (34)

1. Adams V, Moll C, Schmid M, et al. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation. J Med Virol 1996;48:161-70.
2. Astori G, Arzese A, Pipan C, et al. Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 1997;50:57-63.
3. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JO (eds). Diagnostic molecular pathology. A practical approach. Volume II. Cell and tissue genotyping. Oxford: IRL Press at Oxford University Press, 1992:131-52.
4. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
5. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
6. Coutlee F, Mayrand MH, Provencher D, et al. The future of HPV testing in clinical laboratories and applied virology research. Clin Diagn Virol 1997;8:123-41.
7. Cox JT. HPV DNA testing: clinical boon or boondoggle? Lancet 1995;346:717-19.
8. de Roda H, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
9. de Villiers EM, Lavergne D, McLaren K, et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients, Int J Cancer 1997;73:356-61.
10. Feoli-Fonseca JC, Oligny LL, Filion M, et al. Direct human papillomavirus (HPV) sequencing method yields a novel HPV in a human immunodeficiency virus-positive quebec woman and distinguishes a new HPV clade. J Infect Dis 1998;178:1492-6.
11. Feoli-Fonseca JC, Oligny LL, Filion M, et al. JC9813-A Putative novel human papillomavirus identified by PCR-DS. Biochem Biophys Res Commun 1998;250:63-7.
12. Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences (human papillomaviruses compendium). Los Alamos National Laboratory, 1997. URL: http://hpv-web.lanl.gov/
13. Jacobs MV, de Roda H, van den Brule AJ, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
14. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35: 791-5.
15. Johnson K. Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination. CMAJ 1995;152:483-93.
16. Kaufman RH, Adam E, Icenogle J, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997;176:87-92.
17. Longuet M, Cassonnet P, Orth G. A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol 1996;34:1859-62.
18. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996a;22:629-36.
19. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996b;23: 707-30.
20. Lorincz AT, Temple GF, Kurman RJ, et al. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 1987;79:671-7.
21. Manos MM, Ting Y, Wright D, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
22. Manos MM, Waldman J, Zhang TY, et al. Epidemiology and parliai nucleotide sequence of four novel genital human papillomaviruses [published erratum appears in J Infect Dis 1996;173:516]. J Infect Dis 1994;170:1096-9.
23. Mant C, Kell B, Best JM, et al. Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types -6, -11, -16, -18, -31 and -33. J Virol Methods 1997;66:169-78.
24. Munoz N, Bosch FX. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Organ 1996;30:362-77.
25. Ong CK, Bernard HU, Villa LL. Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians. J Infect Dis 1994;170:1086-8.
26. Peyton CL, Jansen AM, Wheeler CM, et al. A novel human papillomavirus sequence from an international cervical cancer study. J Infect Dis 1994;170:1093-5.
27. Shamanin V, Delius H, de Villiers EM. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994;75:1149-56.
28. Skyldberg B, Hagmar B, Johansson B, et al. HPV detection in cytological cases with condylomatous or dysplastic changes: a study with PCR and in situ hybridization on cytological material. Diagn Cytopathol 1995;13:8-14.
29. Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol 1996;175:1091-8.
30. Trofatter KFJ. Diagnosis of human papillomavirus genital tract infection. Am J Med 1997;102:21-7.
31. Troungos C, Horti M, Kittas C. A rapid method for the screening and typing of high risk HPVs using molecular biology techniques. Anticancer Res 1995;15:2045-8.
32. Tucker RA, Johnson PR, Reeves WC, et al. Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results. J Virol Methods 1993;43:321-33.
33. Walker F, Darai E, Dauge-Geffroy MC, et al. Infection genitale a papilloma virus humain (PVH): depistage et typage viral, interet de l'hybridation in situ. Ann Pathol 1996;16:364-73.
34. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-F78.